Hearts harvested from pigs may soon help solve chronic shortages of these donor organs

October 07, 2020

BOSTON - The goal of harvesting hearts from pigs to solve the chronic shortage of these donor organs appears to be in reach, according to a new scientific review by researchers at Massachusetts General Hospital (MGH). This analysis, published in the journal , describes how recent breakthroughs in genetic engineering and drug development led to the recent successful transplantation of pig hearts into baboons by a team in Germany. This pioneering cardiac xenotransplantation--implanting a heart from one species into another--could help prolong and save countless human lives.

A heart transplant is often the only hope of survival for patients with severe heart failure and certain other cardiac conditions that don't respond to other treatments. In 2019, surgeons in the United States performed 3,552 heart transplants, according to the United Network for Organ Sharing. A patient in need of a new heart typically waits more than six months for a donor organ to become available, and often much longer. For many, the wait is too long.

Lead author Richard N. Pierson III, MD, an investigator in MGH's Division of Cardiac Surgery, and his coauthors discuss the scientific breakthroughs that have overcome obstacles to cardiac xenotransplantation. For example, the immune systems of baboons and other primates (including, presumably, humans) recognize pig hearts as "foreign" and attack them, leading to organ rejection. In response, scientists have used genetic engineering techniques to produce pigs whose organs lack certain carbohydrates that are the principal targets of the immune system.

Genetic engineering has also helped solve another problem with cardiac xenotransplantation. Early experiments found that incompatibility between proteins in human blood and proteins on the lining of pig blood vessels could cause blood clots. Pierson and his colleagues have contributed to efforts to develop and test pigs that are engineered to carry genes responsible for producing a human version of a protein called thrombomodulin, which keeps clotting under control.

Innovation in drug development has also made cardiac xenotransplantation possible. Transplant recipients must take drugs that suppress the immune system to prevent organ rejection. "But those drugs don't work when you put a pig organ into a baboon," says Pierson, suggesting that conventional immune suppression wouldn't work in humans, either. To solve this problem, Pierson collaborated with other researchers to develop monoclonal antibodies that block "costimulatory" molecules known as CD40 and CD154. These monoclonal antibodies prevent human or baboon immune cells from attacking pig organs much more effectively than conventional immunosuppressants.

Finally, the Circulation review addresses the question of whether transplanting animal organs into humans could transmit infectious diseases, a concern heightened by the current coronavirus pandemic. "That looks quite unlikely," says Pierson. "The culmination of a lot of research and hard work by our group and others over the last 35 years is that it now looks as though pig-to-human heart transplantation is feasible." He predicts that the first humans could receive transplanted pig hearts as soon as the end of 2021.
Richard N. Pierson III, MD, is scientific director of the MGH Center for Transplantation Science and a professor of Surgery at Harvard Medical School. He holds the W. Gerald and Patricia Austen Chair in Cardiac Surgery.

About the Massachusetts General Hospital

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The

Massachusetts General Hospital

Related Massachusetts General Hospital Articles from Brightsurf:

Epidemiology of COVID-19 among incarcerated individuals, staff in Massachusetts jails, prisons
COVID-19 among incarcerated individuals and staff in Massachusetts jails and prisons is described in this observational study, which assesses the association of COVID-19 case rates with decarceration and testing rates.

New Massachusetts poll: COVID-19 dominates views on politics, daily life
The COVID-19 pandemic dominates views of government, politics and virtually all aspects of daily life, according to a new poll of Massachusetts voters that looks at opinions on issues, politics and public figures.

Massachusetts Eye and Ear, Mass General advancing novel gene-based COVID-19 vaccine, AAVCOVID
A unique COVID-19 genetic vaccine program is underway with Mass.

Mass General Hospital researchers identify new 'universal' target for antiviral treatment
Researchers at Massachusetts General Hospital have uncovered a novel potential antiviral drug target that could lead to treatments protecting against a host of infectious diseases.

Mortality rate is cut in half by a lung rescue team at Massachusetts General
A specialized Lung Rescue Team established to evaluate and treat patients with obesity receiving mechanical ventilation due to acute respiratory failure has significantly reduced the risk of mortality

Massachusetts General Hospital performs first-of-its-kind heart transplant in New England
Mass General Hospital recently performed the largest number of adult heart transplants in the country using what are known as Donation after Circulatory Death (DCD) donor hearts.

The Lancet Infectious Diseases: Mortality rates in Ebola survivors after hospital discharge could be five times higher compared with the general population
In the first year after hospital discharge, mortality in Ebola survivors was five times higher than would be expected in general Guinean population (55 deaths versus 11 deaths), according to an observational study of 1,130 people published in The Lancet Infectious Diseases journal.

Massachusetts General study identifies pathway linking socioeconomic status to cardiovascular risk
A biological pathway previously found to contribute to the impact of stress on the risk of cardiovascular disease also may underlie the increased incidence of such disease experienced by individuals with lower socioeconomic status.

Massachusetts General study finds women pay more for over-the-counter moisturizers
A study from dermatologists at Massachusetts General Hospital finds significant, gender-based price discrepancies in facial moisturizing products at three top online retailers - Amazon, Target, and Walmart.

Massachusetts parental consent law leads to delays for minors seeking abortions
Few studies have examined the impact that the judicial bypass process may have on delaying care for minors seeking abortion.

Read More: Massachusetts General Hospital News and Massachusetts General Hospital Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.